社区

to note: The company still anticipates ?rapid growth? in gross-profit dollars this year and intends to ?aggressively? reinvest in the business to chase long-term opportunities, Chief Financial Officer Amy Shapero said on the earnings call.?As a reminder, we are building a portfolio of growth initiatives with different return time horizons that we expect will contribute to Shopify?s growth over the long term,? she said. ?Initiatives like international expansion and Shopify #$%$ which we embarked upon a few years ago, are further ahead in product and market development, and some of our more complex and groundbreaking initiatives like Shopify Fulfillment Network and Shop are still in their early stages.$Shopify(SHOP)$

Black Rock bought 6% of the company and is the second largest holder after Vanguard, big money knows where this is heading after the SECs aproval of 4 crypto ETFs on November 21, December 8, 11 and 24.$Marathon Digital Holdings Inc(MARA)$

So some little "advisory company" makes a negative statement and the stock prices swings. Here's how that works 1. Short a stock. 2. Announce that you expect earnings to disappoint or that the price is unjustified. 3. Cash out your short position and then buy long. 4. Rinse and repeat.$Seagate Technology PLC(STX)$

It doesn't matter, memory is the future and the future is memory virtually every electronic component requires memory, many investors are simply shorted sighted including the funds.,< Amazing$Micron Technology(MU)$

40’s here we come. Then we may see some significant pressure from outside and sweeping changes at the top.$Dow Chemical(DOW)$

The results were bad but not fatal. I think it's best it came out in Ph2 rather than in Ph3. A COVID drug can still be taken to market. The FDA has already called for an Advisory Committee FDA meeting for Merck, so don't expect a quick approval without scrutiny We know it has a viral reduction impact. That was proven in the hospital setting. If the same trial was run as Merck did, the results could have been very similar. We know it works best on high risk individuals. We know Roche did not pull the plug. We know 10$/ share is the cash value of the company We also know they have antivirals for Dengue, Hep C and RSV in the pipeline. Analyst price targets will still be in the $25-40 range once they update their ratings$Atea Pharmaceuticals, Inc.(AVIR)$

People, please don’t sell, just hold or buy more if you can. This stock will surge soon, because CEI is a good company doing good things. Carbon capture, utilisation and storage, is an important emissions reduction technology that can be applied across the energy system. Besides, don’t forget that winter is coming, oil is getting more scarce and expensive.$Camber Energy(CEI)$

This stock will go down due to huge compensation they will have to pay !!! Closing my account , well I mean if i can access it today or tomorrow !$Interactive Brokers(IBKR)$

A 10 PE and 4.5 billion to go in stock buybacks. Sounds like good odds to me! $200 pt$Travelers(TRV)$

1 billion extra doses: Moderna estimates that the positive vote in support of mRNA-1273 at the 50 µg dose level and subsequent approval would result in up to 1 billion extra doses being available for distribution in 2022.$Moderna, Inc.(MRNA)$